EDITORIAL
Published on 09 Jun 2021
Editorial: Immunotherapy in Hepatocellular Carcinoma
doi 10.3389/fonc.2021.698515
- 1,391 views
- Frontiers in Oncology
- Gastrointestinal Cancers
- Research Topics
- Immunotherapy in Hepatocellular Carcinoma
Immunotherapy in Hepatocellular Carcinoma
27k
Total downloads
72k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 29 Mar 2021
Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
doi 10.3389/fonc.2021.589680
- 5,193 views
- 31 citations
REVIEW
Published on 04 Feb 2021
The Roles of circRNAs in Liver Cancer Immunity
doi 10.3389/fonc.2020.598464
- 3,634 views
- 15 citations
REVIEW
Published on 07 Jan 2021
Immune Checkpoint Inhibitors in the Treatment of HCC
doi 10.3389/fonc.2020.601240
- 14,124 views
- 104 citations
REVIEW
Published on 27 Nov 2020
Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma
doi 10.3389/fonc.2020.589908
- 6,400 views
- 32 citations
REVIEW
Published on 15 Oct 2020
Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
doi 10.3389/fonc.2020.590058
- 2,504 views
- 8 citations
MINI REVIEW
Published on 14 Oct 2020
The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer
doi 10.3389/fonc.2020.524205
- 5,721 views
- 39 citations
CLINICAL TRIAL
Published on 09 Oct 2020
Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study
doi 10.3389/fonc.2020.580241
- 3,538 views
- 44 citations
ORIGINAL RESEARCH
Published on 24 Sep 2020
Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance
doi 10.3389/fonc.2020.554165
- 2,072 views
- 10 citations
ORIGINAL RESEARCH
Published on 26 Aug 2020
Clinical Outcomes and Prognosis Factors of Nivolumab Plus Chemotherapy or Multitarget Tyrosine Kinase Inhibitor in Multi-Line Therapy for Recurrent Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Analysis
doi 10.3389/fonc.2020.01404
- 1,882 views
- 12 citations
METHODS
Published on 26 Aug 2020
Efficacy and Safety of SBRT Combined With Camrelizumab and Apatinib in HCC Patients With PVTT: Study Protocol of a Randomized Controlled Trial
doi 10.3389/fonc.2020.01589
- 4,118 views
- 17 citations
ORIGINAL RESEARCH
Published on 30 Jun 2020
Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
doi 10.3389/fonc.2020.01043
- 3,710 views
- 29 citations
Published in
Frontiers in Oncology
- Gastrointestinal CancersOffline
Impact
- 72kTopic views
- 43kArticle views
- 27kArticle downloads